sleep apnea and tirzepatide FDA Approves (Zepbound) as the First Medication for Obstructive What clinicians should know about

Future studies are needed to determine if there is a benefit in NASH reduction or fibrosis regression

If left uncorrected, this could be life threatening, Weber says

Purpose-built for physicians Real-world data show weekly semaglutide effective for weight loss at 3, 6 months In real-world data from adults with overweight or obesity, weekly semaglutide therapy of 1.7 mg or 2.4 mg was effective at 3 and 6 months for weight loss amounts similar to those observed in clinical trials, according to researchers

I dont think were going to shift away [from injectables] because that wave of interest is already happeningbut yet, there needs to be oral [options] as well, Britta Reierson, MD, a metabolic health and primary care physician and the medical director of Knownwell, told Verywell

In the STEP-1 clinical trial extension, participants regained about two-thirds of the weight they had lost within a year of stopping semaglutide